About Us
Purpose‑built for women’s cancers
GAIASO was founded to improve outcomes in women’s cancer through precision radiotheranostics—aiming to support longer, healthier lives.
Our experienced board and management team spans radiopharmaceutical development, clinical execution, capital strategy and women’s health.
Redefining Cancer Care – For Women, by Design
GAIASO Theranostics is a biotechnology company advancing precision radiotheranostics designed specifically for female cancers. We address a persistent gap in modern oncology: women’s biology has been under‑represented in cancer research, diagnosis and treatment.
Grounded in science and guided by purpose, we are building diagnostic and therapeutic solutions designed for clinical relevance and meaningful patient impact.
Why We Were Founded
Despite significant progress in oncology, cancers that predominantly affect women remain underserved by existing radiopharmaceutical and precision medicine approaches. Many technologies have been developed without adequate consideration of female biology - limiting their effectiveness and relevance for women. GAIASO was founded to change this paradigm. Rather than adapting existing solutions, we design our science from the ground up around female cancer biology, unmet need, and real‑world clinical impact.
Our Purpose
GAIASO exists to improve outcomes for women with cancer by developing smarter diagnostics and more precise, targeted therapies—recognising biological difference and clinical urgency.
We believe women deserve cancer solutions that are:
- Designed with intent
- Informed by biology
- Delivered with speed and responsibility
Our Mission
To design and develop next‑generation theranostic products for female cancers by combining deep biological insight, molecular engineering, and translational expertise – accelerating the path from discovery to meaningful patient impact.
Our Vision
A future where female cancers are detected earlier, treated more precisely, and no longer limited by historical gaps in research or care – improving outcomes not only for women, but for families and communities worldwide.
Our Approach
GAIASO takes a focused, integrated approach to innovation:
- We prioritise female cancer indications with the greatest unmet need
- We develop modular theranostic solutions that combine imaging and therapy
- We advance a disciplined pipeline with clear translational pathways
- We collaborate closely with clinicians, scientists, patients and partners
This approach enables us to move faster, remain biologically relevant, and deliver solutions designed to make a real difference in patient care.
Our Values
-
Female patients first
-
Scientific boldness
-
Speed with purpose
-
Compassion and responsibility
